Spots Global Cancer Trial Database for Tomotherapy for Leptomeningeal Metastases
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Tomotherapy for Leptomeningeal Metastases
Official Title: Tomotherapy for Leptomeningeal Metastases: a Single Arm, Single Center, Phase II Trial
Study ID: NCT04178343
Conditions
Interventions
Study Description
Brief Summary: This clinical trial was designed to investigate the efficiency and toxicity of tomotherapy for leptomeningeal metastases.
Detailed Description: This is a single-arm, single center, phase II trial to investigate the feasibility and toxicity of tomotherapy for leptomeningeal metastases, which are defined as leptomeningeal metastases with or without brain metatstases.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Chinese Academy of Medical Sciences, Beijing, Beijing, China
Contact Details
Name: Jianping Xiao, Dr
Affiliation: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
